Flucytosine - Important Safety Information from Mylan IRE Healthcare as approved by the HPRA

Notice type: 3rd Party Publications

Date: 26/05/2020




Problem Or Issue:

Important Safety Information from Mylan IRE Healthcare Ltd regarding Flucytosine: Updated recommendations for the use in patients with dihydropyrimidine dehydrogenase (DPD) deficiency

Important Safety Information Flucytosine



« Back